Oral high-dose progestins as treatment for advanced breast cancer.

about

Progestins in breast cancer treatment. A review.Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer.

P2860

Q35651439-AD9B98EE-2F6F-4ACA-88CC-B4D93DD6852A Q53524818-443E8C7E-90F8-4F73-9832-A5F7212EF67B

P2860

Oral high-dose progestins as treatment for advanced breast cancer.

Item

http://www.wikidata.org/entity/Q44517936

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

1989年學術文章

@zh-hant

name

Oral high-dose progestins as treatment for advanced breast cancer.

@en

Oral high-dose progestins as treatment for advanced breast cancer.

@nl

type

Item

label

Oral high-dose progestins as treatment for advanced breast cancer.

@en

Oral high-dose progestins as treatment for advanced breast cancer.

@nl

prefLabel

Oral high-dose progestins as treatment for advanced breast cancer.

@en

Oral high-dose progestins as treatment for advanced breast cancer.

@nl

P1476

Oral high-dose progestins as treatment for advanced breast cancer.

@en

P2093

Utaaker E

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of response to therapy in advanced breast cancer.

Effects of progestins on estradiol receptor levels in human endometrium.

Induction of human endometrial estradiol dehydrogenase by progestins.

The role of progestins and progesterone receptors in the treatment of breast cancer.

Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

Survival patterns in hormone treated advanced breast cancer.

Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer.

P304

811-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02841868909092313

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stener Kvinnsland

Steinar Lundgren

P577

1989-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20623068

http://www.w3.org/2001/XMLSchema#string

P698

2532917

http://www.w3.org/2001/XMLSchema#string

Oral high-dose progestins as treatment for advanced breast cancer.

about

P2860

P2860

Oral high-dose progestins as treatment for advanced breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698